The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...
Sixth overall for Lantern’s A.I.-driven precision oncology pipelineOrphan designation expands LP-284's potential for an ...
Neoadjuvant, adjuvant, and palliative treatment with imatinib in patients with gastrointestinal stromal tumors. Background: Soft tissue sarcomas are often treated by inadequate resection lacking ...
Soft tissue sarcoma is a type of cancerous tumor that forms in the body’s soft tissues, such as muscle, fat, fibrous tissue, and blood vessels. If it occurs in the shoulder, it might feel like a ...
As part of Elucent’s mission to lead innovation in real-time localization and surgical guidance for soft tissue excision in the treatment of cancer and other diseases, the EnVisio X1 platform sets a ...
Immediate nasal reconstruction post-BCC excision does not elevate re-excision or recurrence risk, supporting its viability. The study analyzed 318 cases, showing no significant difference in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback